Adaptive Biotechnologies
Price & Volume
Stats
See moreOpen | $12.87 |
Previous Close | $12.79 |
Day Range | $12.87-$14.26 |
52W Range | $6.77-$20.76 |
Market Cap | $1.9B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $276.9M |
Revenue Growth (YoY) | 51% |
Gross Profit (12 Mos) | $205.6M |
Diluted EPS | -$0.39 |
News
See moreYahoo Finance • 3 days ago
Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings
Yahoo Finance • 5 days ago
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On
Yahoo Finance • 29 days ago
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now?
Yahoo Finance • 2 months ago
Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 624 |
